Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

EQT AB (publ) half-year report 2020

Active and responsible ownership crucial in challenging timesPlease note that all figures refer to continued operations, excluding Credit, unless stated otherwise  Highlights for Jan-Jun 2020 (Jan-Jun 2019) · Total investments by the EQT funds in the period of EUR 2.0bn (EUR 5.7bn) and total gross fund exits of EUR 0.2bn (EUR 4.3bn) · Fee-generating AUM of EUR 36.5bn as of June 30, 2020 (EUR 36.8bn) · The target size for EQT Infrastructure V was set at EUR 12.5bn as announced on June 30, 2020 · Number of full-time equivalent employees and on-site consultants (FTE plus)

Höegh LNG: Interim results for the quarter and half year ended 30 June 2020

Hamilton, Bermuda, 20 August 2020 - Höegh LNG Holdings Ltd. ("Höegh LNG") todayreports its financial results for the quarter and half year ended 30 June 2020.Highlights for the second quarter of 2020: · EBITDA of USD 57.7 million · Net profit USD 2.9 million · Stable operations despite challenging circumstances caused by Covid-19 · Cost-savings progressing in accordance with plan · Completed the amendment, extension and USD-45-million upsizing of Independence’s debt facility · HLNG 02 bond loan repaid in June · Cash position improved to USD 151.9 million as a

INTERIM REPORT FOR THE SECOND QUARTER 2020

NEW WAVE GROUP ABPERIOD 1 APRIL – 30 JUNE 2020 · Net sales amounted to SEK 1,314.5 million, which was 22 % (22 % in local currencies) lower than last year (SEK 1,689.0 million). · Operating result amounted to SEK 110.1 (119.6) million. · Result for the period amounted to SEK 72.9 (83.7) million. · Earnings per share amounted to SEK 1.11 (1.28). · Cash flow from operating activities amounted to SEK 251.4 (9.0) million. PERIOD 1 JANUARY – 30 JUNE 2020 · Net sales amounted to SEK 2,755.4 million, which was 14 % (15 % in local currencies) lower than last year (SEK 3,193.

Navamedic ASA: Q2 and first half 2020 financial results

Oslo, 20 August 2020 – Navamedic ASA (OSE: NAVA) grew revenues by 5.5% in the first half of 2020 compared to the same period last year. The company reported revenues of NOK 42.1 million in the second quarter of 2020 with an EBITDA of NOK -2.1 million, affected by Covid-19. Navamedic continued to strengthen its growth platform in the period and reiterates its mid- to long-term ambition of building a NOK 500 million company.“In the first half of the year, we took important steps as a pureplay Nordic pharma company targeting growth in Northern Europe. We continued to grow our portfolio of

Otello Corporation announces second quarter results

Oslo, Norway - August 20, 2020 - Otello Corporation today reported financial results for the second quarter, which ended June 30, 2020. Please find the second quarter report (2Q20.pdf) and second quarter presentation (2Q20_presentation.pdf) attached. Webcast: https://www.otellocorp.com/ir Petter Lade, CFO Phone: +47 91143878 E-mail: petterl@otellocorp.com About Otello: Otello holds shares in several different businesses, including (i) AdColony which helps publishers monetize their content through advertising and advertisers reach the audiences that build value for their

Targovax ASA: second quarter and first half 2020 results

Oslo, Norway, 20 August 2020 - Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, today announces its second quarter and first half 2020 results. An online presentation by Targovax's management to investors, analysts and the press will take place at 10:00 CET today (details below). HIGHLIGHTS FOR THE SECOND QUARTER AND FIRST HALF 2020 Data · Announced encouraging clinical and immune data in mesothelioma combining ONCOS-102 and chemotherapy demonstrating that ONCOS-102 activates patients’ immune

Odfjell SE: Good quarter driven by increased chemical tanker earnings

Odfjell SE today reported its results for the second quarter of 2020. The report shows a good performance which was mainly due to increased chemical tanker earnings. Highlights for 2Q20: · EBITDA of USD 82 million, compared with USD 66 million in 1Q20 · EBITDA of USD 74 million from Odfjell Tankers, compared with USD 58 million 1Q20 · EBITDA of USD 8 million from Odfjell Terminals, same as 1Q20 · Net result of USD 31 million compared with USD -4 million last quarter · Adjusted for non-recurring items, net results are USD 17 million in 2Q20 compared with adjusted net

Shape Robotics starts to Deliver new Telerobot Product: The Fable Connect

Company Announcement No. 9-2020Copenhagen, August 20th, 2020Today Shape Robotics delivers the first Fable Connect robots to the first customer. The customer is the Municipality of Køge, Denmark who will use the robots at their schools to provide remote education of homebound children.The new Fable Connect product has been through a successful test-phase with end-customers from June to August. The first shipment consists of six units and in the coming weeks and months the Company plans to gradually increase the production and delivery volumes.The start of delivery is a major

Kojamo plc: Kojamo plc’s Half-Year Financial Report 1 January – 30 June 2020

Kojamo Plc Stock Exchange Release, 20 August 2020 at 8:00 a.m. EESTKojamo plc’s Half-Year Financial Report 1 January – 30 June 2020 Profitable growth, nearly 2,400 apartments under construction This is a summary of the Half-Year Financial Report January–June 2020, which is in its entirety attached to this release and can be downloaded from the company’s website at www.kojamo.fi/investors. Unless otherwise stated, the comparison figures in brackets refer to the corresponding period of the previous year. The figures in this Half-Year Financial Report have not been audited. Summary of

CELLINK has completed directed share issues of SEK 946 million to finance the acquisition of SCIENION AG and create further room for a continued M&A agenda

The Board of Directors of CELLINK AB (publ) (“CELLINK” or the “Company”) has resolved on directed share issues which in total amounts to 5,912,477 new shares of series B (corresponding to approximately 13.8 percent of the total number of outstanding shares in the Company) shares at a subscription price of SEK 160 per share. 4,287,477 shares are issued based on the authorization granted by the extraordinary general meeting on July 16, 2020 and 1,625,000 shares are issued subject to the subsequent approval of an extraordinary general meeting on September 11, 2020 (the “Share Issues”), which

DNB Markets - IAR Systems: Back to business

IAR Systems’ ability to sign one of its largest-ever deal during a global pandemic demonstrates: 1) solid execution; 2) the relative resilience of its business model; and 3) that its offerings are mission-critical for clients, with large OEMs increasingly standardising using its development tools. Underlying, we have raised our 2021–2022e EPS by 12%, although this is more than offset by a 16% FX headwind. We have also raised our fair value to SEK180–250 (SEK150–230).Strategic customers drive Q2 beat. Sales were SEK100m (15% above our forecast), corresponding to -1% organic growth (we

Notice of the Annual General Meeting of Tecnotree Corporation

Tecnotree Corporation Stock Exchange ReleaseAugust 19, 2020 at 21:00Notice of the Annual General Meeting of Tecnotree Corporation Notice is given to the shareholders of Tecnotree Corporation to the Annual General Meeting to be held on Thursday, 10[ ]September 2020, at 9 a.m. at Tecnotree Corporation Headquarters, Miestentie 9 C, 02150 Espoo, Finland. The reception of persons who have registered for the meeting will commence at 8 a.m. Tecnotree takes the coronavirus situation seriously and takes action, preventive precautions in order to hold a general meeting as well as to ensure

Össur hf: Major shareholder announcement

Announcement no. 34/2020 19 August 2020 Please find enclosed major shareholder announcement. Further information David Hreidarsson, Investor Relations Manager, dhreidarsson@ossur.com, +354 661 8225 Helga Daníelsdóttir, Investor Relations Analyst, hdanielsdottir@ossur.com, +354 766 4959 Össur press releases by e-mail If you wish to receive Össur press releases by e-mail please register at http://www.ossur.com/investors About Össur Össur (Nasdaq Copenhagen: OSSR) is a global leader in non-invasive orthopedics that help people live a life without limitations. A

Baseload investigates the possibility of a new strategic partner

Baseload Capital Holding AB (“Baseload” or the “Company”) has decided to investigate the possibility to identify a new strategic partner that may invest alongside the existing shareholders in order to accelerate the deployment of geothermal Heat Power projects.   As of today, Baseload, through its fully owned subsidiary Baseload Capital Sweden AB (publ), has invested into Heat Power projects in Iceland, Japan, Taiwan and in the US. Baseload Capital, as a group, is constantly looking at opportunities for further expansion into selected key markets. Given the capital intensive

Asetek - Share Capital Increase Upon Exercise of Warrants

Reference is made to warrants issued by Asetek A/S, Danish central business register (CVR) no. 34880522 (the "Company"), pursuant to corporate resolutions adopted on October 8, 2013, April 23, 2014, August 12, 2014, August 11, 2015, April 28, 2016, and April 25, 2017 respectively. Pursuant to the applicable warrant terms, the warrants are exercisable in exercise windows open in a four weeks period running from the Company's preliminary announcement of its financial statements or publication of its interim financial report however no later than 7 years after the Subscription Date as

CELLINK announces intention to carry out directed share issues of approximately 13.5% of the outstanding shares to finance the acquisition of SCIENION AG

CELLINK AB (publ) (“CELLINK” or the “Company”) hereby announces its intention to carry out directed share issues of series B shares corresponding to approximately 13.5 percent of the total number of outstanding shares in the Company (the “Share Issues”). The Share Issues will consist of newly issued series B shares corresponding to 10 percent of the total number of outstanding shares in line with the authorization granted by the extraordinary general meeting that was held on July 16, 2020 and additional series B shares corresponding to approximately 3.5 percent of the total number of

CELLINK has entered into an agreement to acquire precision dispensing company Scienion Ag

CELLINK AB (publ) ("CELLINK") has entered into an agreement with the owners of Scienion Ag ("Scienion"), a German life science company focusing on precision dispensing technologies, to acquire all shares for a purchase price on cash- and debt-free basis of 80M euros (the "Acquisition"). 40M euros will be paid in 2,814,032 newly issued shares of series B in CELLINK (the “Consideration Shares”) and the reminder in cash. CELLINK’s Board of Directors will resolve to issue the Consideration Shares in accordance with the authorization from the Annual General Meeting held on December 18, 2019.

#20-288 Delisting of certain Derivatives from NGM

Certain derivatives will be delisted from NGM.For more details see attached files. For further information concerning this NGM notice please contact: Listing department on +46 8 566 390 20 or at listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

#20-287 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

WorkWave Launches Easy-to-Use Custom Digital Forms Solution to Create a Paperless Environment, Improve the Customer Experience and Complete Sales and Service Operations More Quickly

WorkWave Forms allows access to one of the most essential pieces of a service technician’s process - anytime, anywhereHolmdel, NJ - August 19, 2020 - WorkWave [®], a provider of cloud-based software solutions that support every stage of a service business’s lifecycle, today announces the launch of WorkWave Forms, an easy-to-use custom digital form management solution that allows customers to create custom forms tied directly into WorkWave platforms, creating a paperless environment and reducing the time needed to acquire new customers and complete service orders.

New treatment solution for U.S. cervical cancer patients now available for clinical use

Elekta’s Geneva brachytherapy applicator cleared by U.S. Food and Drug AdministrationSTOCKHOLM, August 19, 2020 – Elekta (EKTA-B.ST) announced today that its Geneva Universal Gynecological Applicator recently received U.S. FDA 510(k) clearance, enabling individuals with cervical cancer in the United States to benefit from the applicator’s ability to precisely target brachytherapy, a radiotherapy method in which a radiation source is introduced directly into the cancer. Designed for cervical cancer up to stage IIB, Geneva would be able to help up to 75 percent of patients with locally

Fortum concludes the sale of its district heating business in Järvenpää, Finland

FORTUM CORPORATION INVESTOR NEWS 19 AUGUST 2020 AT 17:00 EEST  Fortum has today concluded the sale of its district heating business in the Järvenpää-Tuusula area in Finland to a consortium consisting of Vantaa Energy Ltd, Infranode, and Keva, as announced on 3 July 2020. The total consideration of the sale on a debt- and cash-free basis is approximately EUR 375 million. Fortum will record a tax exempt capital gain of approximately EUR 290 million in the City Solutions segment’s third-quarter 2020 results. Fortum Corporation Ingela Ulfves, VP, IR and Financial Communications

Axolot Solutions sells its first AxoPur unit

Axolot Solutions has received its first order for an AxoPur® wastewater purification unit, to Colombier Barrier Coatings in Finland.The sold equipment has a capacity of 2 m³/h and will be used for the purification of wastewater and residues from coating of paperboard. The order includes new sales of equipment and an operating license, in addition to a service contract for consumables in the form of a continuous supply of replacement reactors. The initial order value exceeds 500 000 SEK and concerns equipment with a low degree of automation. Colombier Barrier Coatings has since the summer

ExpreS2ion provides update on its expectations to the COVID-19 vaccine program prior to the Q2 2020 report

Hørsholm, Denmark, August 19, 2020 – ExpreS2ion Biotech Holding AB (“ExpreS2ion” or the “Company”) hereby updates the market on its expectations to the development timelines of the COVID-19 vaccine prior to the release of the Company’s Q2 2002 report. The Company now expects the phase III trials to commence as soon as the first half of 2021, with possible market launch before the end of 2021.The Company previously announced that the PREVENT-nCoV consortium, in which the Company is a partner, plans to enter the first clinical Phase I/IIa trial before the end of 2020, with headline results

There are no items matching the current filter
There are no more items matching the current filter
Back to top